CIBC Private Wealth Group Reduces Stake in IDEXX Laboratories

The investment firm sold over 4,200 shares of the veterinary diagnostics company in the third quarter.

Mar. 18, 2026 at 9:14am

Got story updates? Submit your updates here. ›

CIBC Private Wealth Group LLC, a major institutional investor, reduced its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 1.1% in the third quarter of 2026. The firm now owns 370,539 shares of the veterinary diagnostics company's stock, worth $236.7 million at the time of the filing.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. Changes in ownership by major institutional investors can signal shifts in market sentiment and influence the company's stock price.

The details

CIBC Private Wealth Group sold 4,206 shares of IDEXX Laboratories during the third quarter, reducing its total position to 370,539 shares. The firm cited portfolio rebalancing as the reason for the sale. Other major institutional investors, including Bank of New York Mellon Corp and JPMorgan Chase & Co., increased their stakes in IDEXX during the same period.

  • CIBC Private Wealth Group reported the stake reduction in a 13F filing for the third quarter of 2026.

The players

CIBC Private Wealth Group LLC

A major institutional investor and asset management firm.

IDEXX Laboratories, Inc.

A global developer, manufacturer, and provider of diagnostic products and services primarily for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

The reduction in CIBC Private Wealth Group's stake in IDEXX Laboratories is a relatively small change, but it could signal a shift in market sentiment towards the veterinary diagnostics company. Investors will likely monitor IDEXX's performance and any further changes in institutional ownership in the coming quarters.